Articles about GlaxoSmithKline

Sanofi and GlaxoSmithKline's potential COVID-19 vaccine triggered strong immune responses in all adults in preliminary trials, boosting optimism the shot may join the fight against COVID-19 this year.

As COVID-19 continues to wreak havoc around the world, the entire scientific community is progressing forward with the efforts to develop a vaccine that could finally end the pandemic.

Amid an ongoing probe into Ranitidine's reported cancer-causing impurities, GlaxoSmithKline Pharmaceuticals Limited (GSK) has recalled Ranitidine-based antacid Zinetac (150mg and 300mg) in India and other markets.

Humanity is making breakthroughs in every field of science and technology. At the same time, it's struggling to find a cure for something as paltry as the common cold.

Top-global drugmaker GlaxoSmithKline appointed Emma Walmsley as its new CEO.

India is likely to get an anti-malarial drug in the market by 2018, reports said.